CLINICAL TRIALS PROFILE FOR ASPIRIN; DIPYRIDAMOLE
✉ Email this page to a colleague
All Clinical Trials for aspirin; dipyridamole
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000463 ↗ | Post Coronary Artery Bypass Graft (CABG) Study | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1987-04-01 | To determine the relative effectiveness of moderate versus more aggressive lipid lowering, and of low dose anticoagulation versus placebo, in delaying saphenous vein coronary bypass graft atherosclerosis and preventing occlusion of saphenous grafts of patients with saphenous vein coronary bypass grafts placed 1 to 11 years previously. |
| NCT00000496 ↗ | Platelet Drug Trial in Coronary Disease Progression | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1979-12-01 | To determine the effectiveness of the platelet inhibitor drugs dipyridamole and aspirin in reducing the angiographic progression of coronary artery disease over a five-year period and to test the predictive value of the platelet survival half-life in identifying patients with more rapid progression of coronary disease and development of its complications. |
| NCT00000510 ↗ | Platelet-Inhibitor Drug Trial in Coronary Angioplasty | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1983-09-01 | To determine the effectiveness of dipyridamole and aspirin in prevention of restenosis of the dilated lesion in patients who had undergone percutaneous transluminal coronary angioplasty (PTCA). Secondary aims were to determine the effectiveness of platelet inhibitor therapy in reducing the incidence of coronary events and the severity and incidence of angina. |
| NCT00000527 ↗ | Recurrent Carotid Stenosis | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | 1986-08-01 | To determine whether recurrent stenosis following carotid endarterectomy could be reduced by pre- and post-operative oral administration of platelet-inhibiting drugs. |
| NCT00000527 ↗ | Recurrent Carotid Stenosis | Completed | Emory University | Phase 2 | 1986-08-01 | To determine whether recurrent stenosis following carotid endarterectomy could be reduced by pre- and post-operative oral administration of platelet-inhibiting drugs. |
| NCT00067119 ↗ | Aggrenox Prevention of Access Stenosis | Completed | Baystate Medical Center | Phase 3 | 2003-01-01 | The objective of the study is to determine whether Aggrenox (Boehringer-Ingelheim) prolongs primary unassisted patency in newly created arteriovenous grafts. This record previously included information for both the GRAFT and FISTULA trials. |
| NCT00067119 ↗ | Aggrenox Prevention of Access Stenosis | Completed | Boston University | Phase 3 | 2003-01-01 | The objective of the study is to determine whether Aggrenox (Boehringer-Ingelheim) prolongs primary unassisted patency in newly created arteriovenous grafts. This record previously included information for both the GRAFT and FISTULA trials. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for aspirin; dipyridamole
Condition Name
Clinical Trial Locations for aspirin; dipyridamole
Trials by Country
Clinical Trial Progress for aspirin; dipyridamole
Clinical Trial Phase
Clinical Trial Sponsors for aspirin; dipyridamole
Sponsor Name
